Serological Biomarkers and Diversion Colitis: Changes after Stimulation with Probiotics
- PMID: 34063276
- PMCID: PMC8147466
- DOI: 10.3390/biom11050684
Serological Biomarkers and Diversion Colitis: Changes after Stimulation with Probiotics
Abstract
Diversion colitis is a non-specific inflammation of a defunctionalised segment of the colon after a temporary stoma has been performed. This inflammation is associated with an alteration of certain inflammatory serum markers. The aims of this study were, firstly, to evaluate the modification of inflammatory biomarkers after stimulation with probiotics prior to closure of the protective ileostomy. Secondly, to identify if a relationship could be established between the severity of diversion colitis and the alteration of inflammatory biomarkers in the blood. A prospective, randomized, double-blind, controlled study was conducted. Patients who underwent surgery for colorectal carcinoma with protective ileostomy between January 2017 and December 2018 were included, pending reconstructive surgery and with diversion colitis as diagnosis. The sample was randomly divided into a group stimulated with probiotics (SG) (n = 34) and a control group (CG) (n = 35). Histological and endoscopic changes were evaluated after stimulation, after restorative surgery and during the short-term follow-up after surgery, including the correlation with pro-inflammatory biomarkers in blood. As main findings, a significant decrease in C-reactive protein (CRP), Neutrophil/lymphocyte ratio (NLR ratio), and monocyte/lymphocyte ratio (LMR ratio) was observed in the SG versus the CG with a p < 0.001. A significant increase in transferrin values and in the platelet/lymphocyte ratio (PLR) was observed in the SG versus CG after stimulation with probiotics with a p < 0.001. A normalisation of CRP and transferrin levels was observed in the third month of follow-up after closure ileostomy, and NLR, LMR and PLR ratios were equal in both groups. Decreased modified Glasgow prognostic score was found in SG compared to CG after probiotic stimulation (p < 0.001). The endoscopic and histological severity of diversion colitis is associated with a greater alteration of blood inflammatory biomarkers. The stimulation with probiotics prior to reconstructive surgery promotes an early normalization of these parameters.
Keywords: C-reactive protein; Glasgow Pronostic Score; diversion colitis; efferent loop stimulation; inflammatory bowel disease; probiotics; serological biomarkers.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Diversion Colitis and Probiotic Stimulation: Effects of Bowel Stimulation Prior to Ileostomy Closure.Front Med (Lausanne). 2021 Jun 25;8:654573. doi: 10.3389/fmed.2021.654573. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34249962 Free PMC article.
-
Diversion Colitis: Macro and Microscopic Findings after Probiotics Stimulation.Biology (Basel). 2021 Apr 6;10(4):303. doi: 10.3390/biology10040303. Biology (Basel). 2021. PMID: 33917556 Free PMC article.
-
Postoperative Ileus after Stimulation with Probiotics before Ileostomy Closure.Nutrients. 2021 Feb 15;13(2):626. doi: 10.3390/nu13020626. Nutrients. 2021. PMID: 33671968 Free PMC article. Clinical Trial.
-
Neutrophil-to-lymphocyte Ratio, Platelet-to-lymphocyte Ratio, and C-reactive Protein as New and Simple Prognostic Factors in Patients With Metastatic Renal Cell Cancer Treated With Tyrosine Kinase Inhibitors: A Systemic Review and Meta-analysis.Clin Genitourin Cancer. 2018 Jun;16(3):e685-e693. doi: 10.1016/j.clgc.2018.01.010. Epub 2018 Feb 2. Clin Genitourin Cancer. 2018. PMID: 29454639
-
Diversion proctocolitis and the problem of the forgotten rectum in inflammatory bowel diseases: A systematic review.United European Gastroenterol J. 2021 Dec;9(10):1157-1167. doi: 10.1002/ueg2.12175. Epub 2021 Nov 29. United European Gastroenterol J. 2021. PMID: 34845854 Free PMC article.
Cited by
-
Anti-Inflammatory and Anti-Oxidant Impacts of Lentinan Combined with Probiotics in Ulcerative Colitis.Mol Biotechnol. 2024 Oct;66(10):2778-2791. doi: 10.1007/s12033-023-00878-w. Epub 2023 Oct 11. Mol Biotechnol. 2024. PMID: 37819465
-
A nomogram to predict risk factors of frequent defecation early after ileostomy reversal for rectal cancer patients.Ann Transl Med. 2021 Oct;9(20):1595. doi: 10.21037/atm-21-4660. Ann Transl Med. 2021. PMID: 34790801 Free PMC article.
-
Gut microbial metabolome in inflammatory bowel disease: From association to therapeutic perspectives.Comput Struct Biotechnol J. 2022 Apr 4;20:2402-2414. doi: 10.1016/j.csbj.2022.03.038. eCollection 2022. Comput Struct Biotechnol J. 2022. PMID: 35664229 Free PMC article. Review.
-
Systemic Immune-Inflammation Index: A Promising, Non-Invasive Biomarker for Crohn's Disease Activity and Severity Assessment.Int J Gen Med. 2025 Jan 30;18:483-496. doi: 10.2147/IJGM.S495692. eCollection 2025. Int J Gen Med. 2025. PMID: 39901979 Free PMC article.
-
The Effect of Probiotics on the Prognostication of the Neutrophil-to-Lymphocyte Ratio in Severe Multi-Trauma Patients.J Pers Med. 2024 Apr 15;14(4):419. doi: 10.3390/jpm14040419. J Pers Med. 2024. PMID: 38673046 Free PMC article.
References
-
- Costa M.D., Vieira de Melo C.Y., Amorim A.C., Cipriano Torres De O., Dos Santos A.C. Association Between Nutritional Status, Inflammatory Condition, and Prognostic Indexes with Postoperative Complications and Clinical Outcome of Patients with Gastrointestinal Neoplasia. Nutr. Cancer. 2016;68(7):1108–1114. doi: 10.1080/01635581.2016.1206578. - DOI - PubMed
-
- Delcea C., Dima A., Jurcut C., Caraiola S., Badea C., Nitescu D., Balanescu E., Nicolau A., Pompilian V., Ionescu R., et al. FRI0581 Utility of the Glasgow Prognostic Score in Systemic Lupus Erythematosus, In a Single Center Cohort of 130 Patients. Ann. Rheum. Dis. 2015;74:638.2–638. doi: 10.1136/annrheumdis-2015-eular.6081. - DOI
-
- Zhao C., Ding C., Xie T., Zhang T., Dai X., Wei Y., Li Y., Gong J., Zhu W. Validation and optimization of the Systemic Inflammation-Based modified Glasgow Prognostic Score in predicting postoperative outcome of inflammatory bowel disease: Preliminary data. Sci. Rep. 2018;8:747. doi: 10.1038/s41598-017-18771-3. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous